secwatch.observer — SEC 8-K summary
======================================

Issuer:     Paratek Pharmaceuticals, Inc. (—)
CIK:        0001178711
Form:       8-K
Filed at:   2023-03-14T23:59:59+00:00
Accession:  0001628280-23-007771
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Paratek amends bylaws to comply with SEC universal proxy rules and DGCL updates
-------------------------------------------------------------------------------

- Board approved Amended and Restated Bylaws effective March 9, 2023.
- Bylaws update procedural requirements for stockholder director nominations under SEC universal proxy rules.
- Removes requirement to produce a stockholder list at meetings; adds Rule 14a-19 compliance mandate.
- Prohibits additional or substitute nominations after the deadline and requires stockholder appearance at meetings.
- Reserves white proxy cards for company use; other solicitors must use a different color.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178711/000162828023007771/0001628280-23-007771-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178711/000162828023007771/prtk-20230314.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-007771

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer